# FDA 483 - Sciegen Pharmaceuticals Inc - January 09, 2015

Source: https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/5e31791b-c59c-42d6-8153-31d0bd380825

> FDA 483 for Sciegen Pharmaceuticals Inc on January 09, 2015. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Sciegen Pharmaceuticals Inc
- Inspection Date: 2015-01-09
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: An FDA inspection of Sciegen Pharmaceuticals Inc. in Hauppauge, NY, revealed that the firm's quality control unit procedures were not fully followed. Specifically, a laboratory investigation into duplicate sample sets for Metformin Hydrochloride Tablets was deemed inadequate. The firm failed to determine the root cause of the event and did not conduct a comprehensive review of electronic files and associated audit trails.

## Related Documents

- [483 - 2011-09-16](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/1d284827-ee38-4511-b570-a5c012157fbc)
- [483 - 2021-12-20](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/1634f312-1a9c-465b-9cc8-830b78799bbc)
- [483 - 2022-09-02](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/500247d4-c1a2-41f6-9bee-15b0e37ef216)
- [483 - 2023-04-17](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/e2f9042a-4ff1-46f0-bbb2-f2cb753419c1)

## Related Officers

- [Biotechnology Specialist at FDA](https://www.keypedia.com/people/robert-c-horan/81b78f43-200d-4eaa-a586-fe2101759ffd)

Company: https://www.keypedia.com/companies/sciegen-pharmaceuticals-inc/814ff2a4-e264-431f-bffa-9932abda619d

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961